• LAST PRICE
    6.0500
  • TODAY'S CHANGE (%)
    Trending Down-0.3300 (-5.1724%)
  • Bid / Lots
    6.0700/ 20
  • Ask / Lots
    7.1000/ 1
  • Open / Previous Close
    6.3200 / 6.3800
  • Day Range
    Low 5.8450
    High 6.6600
  • 52 Week Range
    Low 3.2100
    High 10.6899
  • Volume
    51,895
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.38
TimeVolumeCOYA
09:32 ET7206.32
10:03 ET1606.3904
10:19 ET4006.32
10:32 ET2006.35
10:35 ET7126.32
10:51 ET8006.17
10:57 ET12006.06
11:04 ET1506.1077
11:08 ET14506.122
11:09 ET1006.21
11:11 ET5006.18
11:31 ET23006.24
11:33 ET1006.28
11:40 ET5436.22
11:56 ET4006.2892
12:00 ET2006.29
12:02 ET6896.3286
12:03 ET7006.3
12:05 ET2006.355
12:07 ET12016.3
12:09 ET66556.3
12:12 ET2006.3
12:14 ET1006.3
12:16 ET3006.26
12:27 ET1006.23
12:48 ET1006.2
01:01 ET1316.2
01:12 ET12226.22
01:15 ET1046.335
01:17 ET3756.275
01:21 ET1006.21
01:37 ET1156.2395
01:48 ET1006.22
01:57 ET2006.31
02:08 ET67966.3
02:20 ET1006.23
02:26 ET15006.21
02:31 ET1006.2201
02:36 ET5006.22
02:45 ET8266.21
02:58 ET1006.18
03:07 ET1006.21
03:16 ET9186.18
03:21 ET2226.18
03:32 ET1006.14
03:45 ET1006.11
03:48 ET3006.11
03:50 ET9906.1
03:52 ET1006.07
03:54 ET7026
03:56 ET14575.9007
03:57 ET11595.92
03:59 ET38386.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCOYA
Coya Therapeutics Inc
88.4M
-6.8x
---
United StatesCLSD
Clearside Biomedical Inc
80.7M
-2.0x
---
United StatesKRON
Kronos Bio Inc
64.9M
-0.5x
---
United StatesCUE
Cue Biopharma Inc
65.7M
-1.3x
---
United StatesIKNA
Ikena Oncology Inc
83.0M
-1.1x
---
United StatesARMP
Armata Pharmaceuticals Inc
106.3M
-1.3x
---
As of 2024-06-22

Company Information

Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. Its initial developmental programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases of high unmet medical need. Its diversified candidate pipeline includes both ex vivo and in vivo approaches. Its product candidate pipeline is based on its three therapeutic modalities. The product candidates utilizing its Treg-enhancing biologics are collectively referred to as the 300 Series. The product candidates utilizing its Treg-derived exosomes are collectively referred to as the 200 Series. The product candidates utilizing its autologous Treg cell therapy are collectively referred to as the 100 Series. The Company's 300 Series product candidates include COYA 301 and COYA 302.

Contact Information

Headquarters
5850 San Felipe St., Suite 500HOUSTON, TX, United States 77057
Phone
650-739-3939
Fax
302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer
Howard Berman
President, Chief Medical Officer
Fred Grossman
Chief Financial Officer, Chief Operating Officer
David Snyder
Director
Wilbur Ross
Director
Dieter Weinand

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$88.4M
Revenue (TTM)
$6.1M
Shares Outstanding
14.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.89
Book Value
$2.47
P/E Ratio
-6.8x
Price/Sales (TTM)
14.4
Price/Cash Flow (TTM)
---
Operating Margin
-171.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.